Multidrug resistance protein-6 (MRP6) in human dermal fibroblasts. Comparison between cells from normal subjects and from Pseudoxanthoma elasticum patients

Matrix Biology

Volumn 22, Issue 6, 2003, Pages 491-500

  Boraldi, F ^a   Quaglino, D ^a   Croce, M A ^a   Garcia Fernandez, M I ^a   Tiozzo, R ^a   Gheduzzi, D ^a   Bacchelli, B ^a   Pasquali Ronchetti, I ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

ABCC6; Fibroblast; Membrane transporter; MRP6; Pseudoxanthoma elasticum

Indexed keywords

BENZBROMARONE; CALCEIN; CHLORAMBUCIL; INDOMETACIN; MULTIDRUG RESISTANCE PROTEIN 6; VERAPAMIL; VERLUKAST; VINBLASTINE;

ADULT; ARTICLE; CELL STRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; FIBROBLAST; GENE MUTATION; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN SECRETION; PSEUDOXANTHOMA ELASTICUM; SKIN FIBROBLAST;

EID: 0345118903     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2003.09.001     Document Type: Article

References (35)

1. Ashihara T., Baserga R. Cell synchronization. Methods Enzymol. 58:1979;248-262.
2. Baccarani-Contri M., Boraldi F., Taparelli F., De Paepe A., Pasquali Ronchetti I. Matrix proteins with high affinity for calcium ions are associated with mineralization within the elastic fibers of Pseudoxanthoma elasticum dermis. Am. J. Pathol. 148:1996;569-577.
3. Bacchelli B., Quaglino D., Gheduzzi D., et al. Identification of heterogygote carriers in families with a recessive form of Pseudoxanthoma elasticum (PXE). Mod. Pathol. 12:1999;1112-1123.
4. Barnouin K., Leier I., Jedlitschky G., et al. Multidrug resistance protein-mediated transport of chlorambucil and melphalan conjugated to glutathione. Br. J. Cancer. 77:1998;201-209.
5. Begleiter A., Mowat M., Israels L.G., Johnston J.B. Chlorambucil in chronic lymphocytic leukemia: mechanism of action. Leuk. Lymphoma. 23:1996;187-201.
6. Bergen A.A.B., Plomp A.S., Schuurman E.J., et al. Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat. Genet. 25:2000;228-231.
7. Borst P., Evers R., Kool M., Wijnholds J. The multidrug resistance protein family. Biochim. Biophys. Acta. 1461:1999;347-357.
8. Crivellato E., Candussio L., Rosati A.M., Bartoli-Klugmann F., Maliardi F., Decorti G. The fluorescent probe Bodipy-FL-verapamil is a substrate for both P-glycoprotein and multidrug resistance-related protein (MRP)-1. J. Histochem. Cytochem. 50:2002;731-734.
9. Dhar S., Nygren P., Liminga G., et al. Relationships between cytotoxic drug response patterns and activity of drug efflux transporters mediating multidrug resistance. Eur. J. Pharmacol. 346:1998;315-322.
10. Essodaigui M., Broxterman H.J., Garnier-Suillerot A. Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein. Biochemistry. 37:1998;2243-2250.
11. Feller N., Broxterman H., Wahrer D., Pinedo H. ATP-dependent efflux of calcein by the multidrug resistance protein (MRP): no inhibition by intracellular glutathione depletion. FEBS Lett. 386:1995;385-388.
12. Flanagan S.D., Cummins C.L., Susanto M., Liu X., Takahashi L., Benet L.Z. Comparison of furosemide and vinblastine secretion from cell lines overexpressing multidrug resistance protein (P-glycoprotein) and multidrug resistance-associated proteins (MRP1 and MRP2). Pharmacology. 64:2002;126-134.
13. Gheduzzi, D., Sammarco, R., Quaglino, D., et al., Extracutaneous ultrastructural alterations in pseudoxanthoma elasticum. Ultrastruc. Pathol., in press.
14. Hamilton K.O., Topp E., Makagiansar I., Siahaan T., Yazdanian M., Audus K.L. Multidrug-associated-protein 1 functional activity in colu-3 cells. J. Pharmacol. Exp. Ther. 298:2001;1199-1205.
15. Hipfner D.R., Deeley R.G., Cole S.P.C. Structural, mechanistic and clinical aspects of MRP1. Biochim. Biophys. Acta. 1461:1999;359-376.
16. Hollo Z. Calcein accumulation as a fluorimetric functional assay of the multidrug transporter. Biochim. Biophys. Acta. 384:1994;1191-1198.
17. Homolya L., Hollo M., Muller M., Mechetner E.B., Sarkadi B. A new method for quantitative assessment of P-glycoprotein-related multidrug resistance in tumor cells. Br. J. Cancer. 73:1996;849-855.
18. Ilias A., Urban Z., Seidi T.L., et al. Loss of the ATP-depending transport activity in Pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6). J. Biol. Chem. 277:2002;16860-16867.
19. Klein I., Sarkadi B., Varadi A. An inventory of the human ABC proteins. Biochim. Biophys. Acta. 1461:1999;237-262.
20. Kool M., van der Linden M., de Haas M., Baas F., Borst P. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res. 59:1999;175-182.
21. Le Saux O., Urban Z., Tschuch C., et al. Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum. Nat. Genet. 25:2000;223-227.
22. Le Saux O., Beck K., Sachsinger C., et al. A spectrum of ABCC6 mutations is responsible for Pseudoxanthoma elasticum. Am. J. Hum. Gen. 69:2001;749-764.
23. Maccari F., Gheduzzi D., Volpi N. Anomalous structure of urinary glycosaminoglycans in patients with pseudoxanthoma elasticum. Clin. Chem. 49:2003;380-388.
24. Madon J., Hagenbuch B., Landmann L., Meier P.J., Stieger B. Transport function and hepatocellular localization of MRP6 in rat liver. Mol. Pharmacol. 57:2000;634-641.
25. Neldner K., Struck B. Pseudoxanthoma elasticum. Royce P.M., Steinmann B. Connective Tissue and Its Heritable Disorders. Molecular, Genetic and Medical Aspects. 2002;561-583 Wiley-Liss & Sons, Inc. Publ.
26. Ogawa K., Suzuki H., Hirohashi T., et al. Characterization of inducible nature of MRP3 in rat liver. Am. J. Physiol. Gastrointest. Liver Physiol. 278:2000;G438-446.
27. Pasquali-Ronchetti I., Volpin D., Baccarani-Contri M., Castellani I., Peserico A. Pseudoxanthoma elasticum: biochemical and ultrastructural study. Dermatologica. 163:1981;307-326.
28. Pasquali-Ronchetti I., Baccarani-Contri M., Pincelli C., Bertazzoni M.G. Effect of selective enzymatic digestions on skin biopsies from Pseudoxanthoma elasticum patients. Arch. Dermatol. Res. 278:1986;386-392.
29. Passi A., Albertini R., Baccarani-Contri M., et al. Proteoglycan alterations in skin fibroblast cultures from patients affected with Pseudoxanthoma elasticum. Cell Biochem. Funct. 14:1996;111-120.
30. Pulaski L., Jedlitschky G., Leier I., Buchholz U., Keppler D. Identification of the multidrug resistance protein (MRP) as the glutathione-S-conjugate export pump of erythrocytes. Eur. J. Biochem. 24:1996;644-648.
31. Quaglino D., Boraldi F., Barbieri D., Croce A., Tiozzo R., Pasquali-Ronchetti I. Abnormal phenotype of in vitro dermal fibroblasts from patients with pseudoxanthoma elasticum (PXE). Biochim. Biophys. Acta. 1501:2000;51-62.
32. Ringpfeil F., Lebwohl M.G., Christiano A.M., Uitto J. Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. PNAS. 97:2000;6001-6006.
33. Scheffer G.L., Hu X., Pijnenborg A.C.L.M., Wijnholds J., Bergen A.A.B., Scheper R.J. MRP6 (ABCC6) detection in normal human tissues and tumors. Lab. Invest. 82:2002;515-518.
34. Tiozzo-Costa R., Baccarani-Contri M., Cingi M.R., et al. Pseudoxanthoma elasticum (PXE): ultrastructural and biochemical study on proteoglycan and proteoglycan-associated material produced by skin fibroblasts in vitro. Collagen Rel. Res. 8:1988;49-64.
35. Vertessy B.G., Kovacs J., Low P., et al. Characterization of microtubule-phosphofructokinase complex: specific effects of MgATP and vinblastine. Biochemistry. 36:1997;2051-2062.